Long-Term Outcomes of Pediatric Renovascular Hypertension

Background/Aims: Renovascular hypertension (RVHT) is an important cause of childhood hypertension. This study evaluated the clinical characteristics and outcomes of Korean children with RVHT. Methods: Children treated for RVHT between 2000 and 2015 at our center were retrospectively reviewed. Result...

Full description

Bibliographic Details
Main Authors: Hyun Chung, Jae Hwan Lee, Eujin Park, Hyesun Hyun, Yo Han Ahn, Hwan Jun Jae, Gi Beom Kim, Il Soo Ha, Hae Il Cheong, Hee Gyung Kang
Format: Article
Language:English
Published: Karger Publishers 2017-09-01
Series:Kidney & Blood Pressure Research
Subjects:
Online Access:http://www.karger.com/Article/FullText/481549
_version_ 1811222775169286144
author Hyun Chung
Jae Hwan Lee
Eujin Park
Hyesun Hyun
Yo Han Ahn
Hwan Jun Jae
Gi Beom Kim
Il Soo Ha
Hae Il Cheong
Hee Gyung Kang
author_facet Hyun Chung
Jae Hwan Lee
Eujin Park
Hyesun Hyun
Yo Han Ahn
Hwan Jun Jae
Gi Beom Kim
Il Soo Ha
Hae Il Cheong
Hee Gyung Kang
author_sort Hyun Chung
collection DOAJ
description Background/Aims: Renovascular hypertension (RVHT) is an important cause of childhood hypertension. This study evaluated the clinical characteristics and outcomes of Korean children with RVHT. Methods: Children treated for RVHT between 2000 and 2015 at our center were retrospectively reviewed. Results: Forty-six children were followed for a median of 6.5 (0.66-27.23) years. Forty-five percutaneous transluminal angioplasties (PTAs) were performed in 32 children. At the last visit, clinical benefit was observed in 53.3% of children. Patients with comorbid cerebrovascular disease (CVD) showed less favorable long-term outcomes after PTA (clinical benefit in 41.7% vs. 61.1% in others) and higher restenosis rates (50% vs. 31.6% in others). Surgical procedures (bypass or nephrectomy) were performed in 8 patients. After surgery, blood pressure was normalized in 2 patients, improved in 3 patients, and unchanged in the remaining patients. Between PTA group (n=21) and medication group (n=14), percentage of atrophic kidneys became higher after follow-up period in medication group than in PTA group (60.0% vs. 26.1%, P=0.037). Conclusion: Aggressive treatment of pediatric RVHT yielded fair outcomes in our cohort. CVD comorbidity was associated with relatively poor PTA outcomes. To confirm our findings, larger cohort studies with a longer follow-up period are warranted.
first_indexed 2024-04-12T08:20:54Z
format Article
id doaj.art-5663df331b8f4a758b7c8c57fb0e6b75
institution Directory Open Access Journal
issn 1420-4096
1423-0143
language English
last_indexed 2024-04-12T08:20:54Z
publishDate 2017-09-01
publisher Karger Publishers
record_format Article
series Kidney & Blood Pressure Research
spelling doaj.art-5663df331b8f4a758b7c8c57fb0e6b752022-12-22T03:40:35ZengKarger PublishersKidney & Blood Pressure Research1420-40961423-01432017-09-0142361762710.1159/000481549481549Long-Term Outcomes of Pediatric Renovascular HypertensionHyun ChungJae Hwan LeeEujin ParkHyesun HyunYo Han AhnHwan Jun JaeGi Beom KimIl Soo HaHae Il CheongHee Gyung KangBackground/Aims: Renovascular hypertension (RVHT) is an important cause of childhood hypertension. This study evaluated the clinical characteristics and outcomes of Korean children with RVHT. Methods: Children treated for RVHT between 2000 and 2015 at our center were retrospectively reviewed. Results: Forty-six children were followed for a median of 6.5 (0.66-27.23) years. Forty-five percutaneous transluminal angioplasties (PTAs) were performed in 32 children. At the last visit, clinical benefit was observed in 53.3% of children. Patients with comorbid cerebrovascular disease (CVD) showed less favorable long-term outcomes after PTA (clinical benefit in 41.7% vs. 61.1% in others) and higher restenosis rates (50% vs. 31.6% in others). Surgical procedures (bypass or nephrectomy) were performed in 8 patients. After surgery, blood pressure was normalized in 2 patients, improved in 3 patients, and unchanged in the remaining patients. Between PTA group (n=21) and medication group (n=14), percentage of atrophic kidneys became higher after follow-up period in medication group than in PTA group (60.0% vs. 26.1%, P=0.037). Conclusion: Aggressive treatment of pediatric RVHT yielded fair outcomes in our cohort. CVD comorbidity was associated with relatively poor PTA outcomes. To confirm our findings, larger cohort studies with a longer follow-up period are warranted.http://www.karger.com/Article/FullText/481549Renovascular hypertensionPediatricsTreatmentAngioplastyLong-term outcome
spellingShingle Hyun Chung
Jae Hwan Lee
Eujin Park
Hyesun Hyun
Yo Han Ahn
Hwan Jun Jae
Gi Beom Kim
Il Soo Ha
Hae Il Cheong
Hee Gyung Kang
Long-Term Outcomes of Pediatric Renovascular Hypertension
Kidney & Blood Pressure Research
Renovascular hypertension
Pediatrics
Treatment
Angioplasty
Long-term outcome
title Long-Term Outcomes of Pediatric Renovascular Hypertension
title_full Long-Term Outcomes of Pediatric Renovascular Hypertension
title_fullStr Long-Term Outcomes of Pediatric Renovascular Hypertension
title_full_unstemmed Long-Term Outcomes of Pediatric Renovascular Hypertension
title_short Long-Term Outcomes of Pediatric Renovascular Hypertension
title_sort long term outcomes of pediatric renovascular hypertension
topic Renovascular hypertension
Pediatrics
Treatment
Angioplasty
Long-term outcome
url http://www.karger.com/Article/FullText/481549
work_keys_str_mv AT hyunchung longtermoutcomesofpediatricrenovascularhypertension
AT jaehwanlee longtermoutcomesofpediatricrenovascularhypertension
AT eujinpark longtermoutcomesofpediatricrenovascularhypertension
AT hyesunhyun longtermoutcomesofpediatricrenovascularhypertension
AT yohanahn longtermoutcomesofpediatricrenovascularhypertension
AT hwanjunjae longtermoutcomesofpediatricrenovascularhypertension
AT gibeomkim longtermoutcomesofpediatricrenovascularhypertension
AT ilsooha longtermoutcomesofpediatricrenovascularhypertension
AT haeilcheong longtermoutcomesofpediatricrenovascularhypertension
AT heegyungkang longtermoutcomesofpediatricrenovascularhypertension